0001209191-23-045832.txt : 20230815
0001209191-23-045832.hdr.sgml : 20230815
20230815161356
ACCESSION NUMBER: 0001209191-23-045832
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230811
FILED AS OF DATE: 20230815
DATE AS OF CHANGE: 20230815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blank Jeremy
CENTRAL INDEX KEY: 0001962987
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38716
FILM NUMBER: 231174978
MAIL ADDRESS:
STREET 1: 6446 DREXEL AVENUE
CITY: LOS ANGELES
STATE: CA
ZIP: 90048
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gamida Cell Ltd.
CENTRAL INDEX KEY: 0001600847
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 NAHUM HAFZADI STREET
CITY: JERUSALEM
STATE: L3
ZIP: 95484
BUSINESS PHONE: 97226595666
MAIL ADDRESS:
STREET 1: 5 NAHUM HAFZADI STREET
CITY: JERUSALEM
STATE: L3
ZIP: 95484
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-11
0
0001600847
Gamida Cell Ltd.
GMDA
0001962987
Blank Jeremy
C/O GAMIDA CELL LTD.
116 HUNTINGTON AVENUE
BOSTON
MA
02116
1
0
0
0
0
Ordinary Shares
2023-08-11
4
A
0
4000
0.00
A
4000
D
Ordinary Shares
5169471
I
By Community Master Fund, LP
Share Option (Right to Buy)
1.22
2023-08-11
4
A
0
19000
0.00
A
2033-08-10
Ordinary Shares
19000
19000
D
Represents a restricted share unit award, which shall vest on August 11, 2024, subject to the Reporting Person's continuous service through such vesting date.
Securities are held directly by Community Master Fund, LP ("Master Fund"). Community US Fund Management, Inc. (the "Firm") is the investment manager to Master Fund and may be deemed to beneficially own these securities. The Reporting Person is the principal and portfolio manager of the Firm and exercises investment discretion with respect to these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein, if any.
This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on November 11, 2023, subject to the Reporting Person's continuous service through each such vesting date.
/s/ Joshua F. Patterson, Attorney-in-Fact
2023-08-15